CRP and acute kidney injury: Non-COVID-19 AKI patients tended to be older (86 ± 8.4 vs 83 ± 8.6) and to have a higher prevalence of diabetes (41% vs 32%), chronic heart failure (32% vs 17%), lower baseline eGFR (47 ± 25 vs 64 ± 21 mL/min), increased initial CRP value( 53 vs 26 mg/L), and more prevalent use of diuretics (72% vs 55%), LMWH/NOAC/warfarin (64% vs 55%) and antibiotics (54% vs 38%) as compared to those without AKI (Table 1).